Pro Med Pl Sp Z O O

What Pro Med Pl Sp Z O O does

PRO.MED.CS Praha a.s. is a privately held Czech pharmaceutical company founded on 1 February 1989 and headquartered in Prague. It operates as a fully integrated generic and value-added medicines manufacturer with in-house capabilities spanning pre-formulation, formulation development, stability studies, manufacturing, packaging design, and worldwide regulatory registrations. Its portfolio of more than 50 branded generic and value-added products covers over 200 indications, primarily in gastroenterology, hepatology, cardiovascular, and central nervous system therapy areas. The flagship asset is the URSOSAN (ursodeoxycholic acid) family, originally launched in 1992 and now extended by URSOSAN FORTE; additional categories include prokinetics (ITOMED, PROSULPIN), acid suppressants and mucosal protectants (REBAGIT, FAMOSAN, SALOZINAL), cardiovascular products (INDAP, NITRESAN, BISOPROLOL PMCS, MONOSAN, PROPANORM), CNS agents (PROSULPIN, TIAPROSAN, AMILIA, RILUZOL PMCS), and selected OTC and anti-infective lines (AMBROSAN, CIFLOXINAL, PROVIRSAN). The company produces more than one billion tablets, coated tablets, and capsules annually under GMP, GDP, and GLP certifications for both EU and Russian Federation markets.

The firm generates revenue through sales of prescription (Rx) and over-the-counter (OTC) pharmaceuticals, with pricing set country-by-country under local regulatory frameworks rather than disclosed publicly. It reaches its markets through a wholly owned branch network of eleven subsidiaries covering Czech Republic, Slovakia, Poland, Germany, Russia, Ukraine, Bosnia and Herzegovina, Kazakhstan, Kyrgyzstan, Uzbekistan, and Mexico (Prometis Pharma), supplemented by partner distributors in additional regions. This direct-presence distribution model — combined with marketing authorizations in more than 30 countries — supports treatment of more than two million patients daily worldwide. Scientific engagement with prescribing physicians is sustained through the long-running Dr. Bares Award (since 1993, currently in its 17th cycle) and the biannual International Symposium of Gastroenterology (14th edition scheduled for 2026 in Tbilisi). The company is family-controlled by the Bares family, with founder Dr. Rudolf O. Bares memorialized in the renamed award since 2005.

Name

Pro Med Pl Sp Z O O

Legal name

PRO.MED.CS Praha a.s.

Website

https://promedcs.com

Company type

Private

Founded year

1989

Operating status

Operating

Short description

PRO.MED.CS Praha a.s. is a Czech-headquartered, family-owned pharmaceutical company that develops, manufactures, and distributes a portfolio of 50+ branded generic and value-added medicines across gastroenterology, hepatology, cardiovascular, and CNS therapy areas, reaching more than two million patients daily across 30+ countries through its own branch network and distribution partners.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Gastroenterology drugs
• Cardiovascular medicines
• Hepatobiliary treatments

Headquarters

HQ city

Prague

HQ country

Czechia

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sales of prescription (Rx) and over-the-counter (OTC) pharmaceutical products including more than 50 medicinal products covering over 200 indications

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

PRO.MED.CS Praha a.s. is a fully integrated pharmaceutical company that develops, manufactures, and markets generic and value-added medicinal products focused on gastrointestinal, hepatobiliary, cardiovascular, and central nervous system diseases. The company operates its own scientific research facilities, GMP-certified manufacturing of tablets, coated tablets, capsules, ampoules, and suppositories, and holds worldwide marketing authorizations, distributing through its own branch network and partners across more than 30 countries.

Product overview

PRO.MED.CS Praha a.s. is a European fully integrated pharmaceutical company with over 50 branded generic products across Rx, OTC, and dietary supplement categories. The product portfolio centers on gastroenterology and hepatology (with flagship URSOSAN/URSOSAN FORTE ursodeoxycholic acid products), cardiovascular diseases (including BISOPROLOL PMCS, RIVOCOR, NITRESAN, MONOSAN, COMBISO, YLPIO), CNS disorders (PROSULPIN, TIAPRID PMCS, RILUZOL PMCS, AMILIA), and anti-infectives. Products are distributed through the company's own sales network in Europe and Eurasian Economic Union, with partner networks in other regions. The portfolio includes over 200 indications serving approximately 2 million patients daily in more than 30 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Dr. Bares Award: International award for best experimental or clinical works in gastroenterology and hepatology, organized by the company since 1993.
• International Symposium of Gastroenterology (ISG)

Products and services

• URSOSAN Ursodeoxycholic acid 250mg Rx product for hepatobiliary disorders including primary biliary cholangitis (PBC), liver diseases, and fatty liver conditions.
• URSOSAN FORTE High-dosage ursodeoxycholic acid 500mg Rx formulation for hepatobiliary disorders with improved dosing convenience compared with URSOSAN.
• AMBROSAN Ambroxol hydrochloride 30mg OTC mucolytic for cough treatment (ATC code R05CB06).
• INDAP Indapamide Rx cardiovascular product in capsules (2.5mg) and tablets (0.625mg/1.25mg/2.5mg) for hypertension treatment.
• ITOMED Itopride hydrochloride 50mg Rx prokinetic agent for gastroenterology indications including functional digestive disorders.
• PROSULPIN Sulpiride 50mg/200mg Rx product for CNS and gastroenterology indications, used as an antipsychotic and prokinetic agent.
• REBAGIT Rebamipide 100mg Rx mucosal protective agent for gastroenterology indications including gastric ulcers and gastritis.
• TIAPROSAN Tiapride hydrochloride 100mg Rx antipsychotic medication for CNS disorders.
• NITRESAN Nitrendipine 10mg/20mg Rx calcium channel blocker for cardiovascular conditions including hypertension treatment.
• PROPANORM Propafenone hydrochloride 150mg/300mg Rx antiarrhythmic agent for cardiac rhythm disorders.
• FAMOSAN Famotidine Rx H2-receptor blocker for gastric acid-related disorders.
• CIFLOXINAL Ciprofloxacin Rx antibiotic for infectious diseases.
• RIVOCOR Bisoprolol Rx cardiovascular product for hypertension and heart conditions.
• BISOPROLOL PMCS Bisoprolol fumarate Rx beta-blocker for cardiovascular diseases.
• MONOSAN Isosorbide mononitrate Rx product for angina treatment.
• RIVODARON Amiodarone Rx antiarrhythmic medication.
• PROVIRSAN Aciclovir Rx antiviral for herpes infections.
• RILUZOL PMCS Riluzole Rx neuroprotective agent for ALS treatment.
• WARFARIN PMCS Warfarin Rx anticoagulant for thrombosis prevention.
• SOLIFENACIN PMCS Solifenacin Rx urology product for overactive bladder.
• COMBISO Bisoprolol/hydrochlorothiazide Rx combination product for hypertension.
• YLPIO Telmisartan/indapamide Rx combination product for hypertension.
• PROKANAZOL Itraconazole Rx antifungal medication.
• TERFIMED Terbinafine Rx antifungal for skin infections.
• SPASMED Trospium chloride Rx antispasmodic for functional bowel disorders.
• METEOSPASMYL Alverine/simeticone Rx combination for functional digestive disorders.
• GODASAL Acetylsalicylic acid with glycine Rx product for pain and thrombosis.
• SALOZINAL Mesalazine Rx product for inflammatory bowel disease.
• AMILIA Amisulpride Rx product for psychiatric disorders.
• BETAXOLOL PMCS Betaxolol Rx beta-blocker for glaucoma and cardiovascular conditions.
• PERINDOPRIL PMCS Perindopril Rx ACE inhibitor for hypertension.
• CORSIM Simvastatin Rx statin for hypercholesterolemia.

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered minor and core.

• Fair Data ProfessionalsminorImplementation/ SI/ Consulting Partner · 1 January 2023External operator of PRO.MED.CS internal reporting system (Ethics Line). Operates online notification form, phone line, and personal appointment system for whistleblowing reports. Ensures anonymity, confidentiality, and impartiality in assessment of each report per EU Directive 2019/1937.
• Family Bares (Baresova rodina)coreStrategic or Co-development PartnerFamily of company founder Dr. Rudolf O. Bares, long-term General Director and gastroenterology patron. Co-sponsor of Dr. Bares Award since its renaming in 2005 to honor his memory. The family remains connected to the company's scientific mission.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pro Med Pl Sp Z O O